Angiodynamics (ANGO) Payables (2011 - 2026)

Angiodynamics (ANGO) has reported Payables for 16 consecutive years, with $31.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Payables fell 5.34% year-over-year to $31.5 million; the trailing twelve-month figure through May 2026 stood at $31.5 million (down 5.34% YoY), and the FY2026 full-year result was $31.5 million, down 5.34% from the prior year.
• Payables climbed to $31.5 million in Q2 2026 per ANGO's latest filing, from $29.1 million in the prior quarter.
• Across five years, Payables topped out at $40.4 million in Q2 2023 and bottomed at $21.6 million in Q1 2022.
• Historically, Payables has averaged $32.4 million across 5 years, with a median of $32.6 million in 2025.
• The widest YoY moves for Payables: up 65.04% in 2023, down 15.21% in 2023.
• Over 5 years, Payables stood at $34.7 million in 2022, then rose by 8.54% to $37.6 million in 2023, then retreated by 7.71% to $34.7 million in 2024, then gained by 1.85% to $35.4 million in 2025, then slipped by 10.96% to $31.5 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $31.5 million, $29.1 million, and $35.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.